The Fort Worth Press - ONAR Expands Into Healthcare Marketing With Acquisition and Rebranding of VMed to Of Kos

USD -
AED 3.672502
AFN 64.000041
ALL 81.500312
AMD 360.2992
ANG 1.789785
AOA 918.000231
ARS 1538.519772
AUD 1.422951
AWG 1.8025
AZN 1.701509
BAM 1.755348
BBD 2.014118
BDT 124.150744
BGN 1.747831
BHD 0.37735
BIF 3000
BMD 1
BND 1.281553
BOB 11.995315
BRL 5.393101
BSD 1.000013
BTN 95.207367
BWP 13.822349
BYN 2.947868
BYR 19600
BZD 2.01121
CAD 1.395805
CDF 2315.000024
CHF 0.82107
CLF 0.025084
CLP 990.470581
CNY 6.661098
CNH 6.650785
COP 3178.96
CRC 454.76167
CUC 1
CUP 24.000287
CVE 99.195038
CZK 21.7499
DJF 177.720076
DKK 6.678065
DOP 60.650082
DZD 135.675976
EGP 56.0038
ERN 15
ETB 161.150317
EUR 0.89355
FJD 2.24025
FKP 0.747647
GBP 0.744895
GEL 2.599286
GGP 0.747647
GHS 11.649983
GIP 0.747647
GMD 73.999906
GNF 8799.999654
GTQ 7.645879
GYD 209.614159
HKD 7.845325
HNL 26.999829
HRK 6.76901
HTG 131.054259
HUF 326.981499
IDR 18139.15
ILS 3.12505
IMP 0.747647
INR 94.97085
IQD 1514
IRR 1868415.000297
ISK 121.499098
JEP 0.747647
JMD 158.760361
JOD 0.708993
JPY 157.105501
KES 129.950238
KGS 87.448698
KHR 4073.000466
KMF 440.999836
KPW 899.999961
KRW 1334.219869
KWD 0.31098
KYD 0.833326
KZT 453.3167
LAK 22535.000558
LBP 89549.999892
LKR 332.450795
LRD 170.450274
LSL 16.630086
LTL 2.95274
LVL 0.60489
LYD 6.425006
MAD 9.833501
MDL 18.045072
MGA 4595.000132
MKD 55.021155
MMK 2099.909661
MNT 3597.883233
MOP 8.082337
MRU 40.239982
MUR 47.289969
MVR 15.450396
MWK 1736.000168
MXN 18.875204
MYR 4.056963
MZN 63.909948
NAD 16.630024
NGN 1346.380243
NIO 36.810259
NOK 9.217305
NPR 152.332146
NZD 1.772245
OMR 0.384501
PAB 1.000013
PEN 3.460017
PGK 4.49025
PHP 63.67504
PKR 276.600474
PLN 3.93192
PYG 5858.938516
QAR 3.645499
RON 4.772026
RSD 105.012003
RUB 80.649626
RWF 1475
SAR 3.7541
SBD 8.058206
SCR 13.742183
SDG 601.500517
SEK 9.809045
SGD 1.27776
SHP 0.748335
SLE 22.900107
SLL 20969.504398
SOS 571.501218
SRD 37.644503
STD 20697.981008
STN 22.3
SVC 8.749697
SYP 13001.999685
SZL 16.630353
THB 33.716499
TJS 9.190174
TMT 3.5
TND 3.020699
TOP 2.40776
TRY 49.947455
TTD 6.779691
TWD 32.599499
TZS 2648.258019
UAH 45.55389
UGX 4360.137679
UYU 40.22581
UZS 11994.999742
VES 887.479804
VND 25803.5
VUV 119.217464
WST 2.773901
XAF 586.130493
XAG 0.01996
XAU 0.000252138131
XCD 2.70255
XCG 1.802288
XDR 0.707052
XOF 586.130493
XPF 107.303848
YER 236.196986
ZAR 16.66562
ZMK 9001.197294
ZMW 20.200416
ZWL 321.999592
SSP 5745.199062
MXV 2.127338
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

ONAR Expands Into Healthcare Marketing With Acquisition and Rebranding of VMed to Of Kos
ONAR Expands Into Healthcare Marketing With Acquisition and Rebranding of VMed to Of Kos

ONAR Expands Into Healthcare Marketing With Acquisition and Rebranding of VMed to Of Kos

ONAR (OTCQB:RELT), a global network of marketing agencies, is excited to announce its acquisition of VMed and the subsequent rebranding to Of Kos.

Text size:

The acquisition began as early as March of 2023, but its more recent strategic transformation underscores ONAR's visionary drive to position the agency at the forefront of the healthcare marketing industry.As ONAR expands its expertise to new and emerging markets, Of Kos aligns with its robust acquisition strategy by adding healthcare marketing to ONAR's matrix of specializations.

Why Of Kos?

The name "Of Kos" is in reference to the father of modern medicine, Hippocrates of Kos, as the company continues the noble tradition of providing the right treatments, to the right people, at the right time.

Strategic Acquisition of VMed

Formerly VMed, the company began by going from practice to practice to help doctors streamline their testing procedures. They also built face-to-face, direct relationships with caregivers and delivered results that impacted both their patients' wellbeing and their practices' bottom line. VMed was founded by Michael Stevens, who will stay on as a consultant for Of Kos, overseeing its continued expansion within the ONAR ecosystem.

Key Reasons for the Rebrand

- Enhanced Market Presence: The rebranding to Of Kos positions ONAR as a trailblazer in the healthcare marketing industry, reflecting their traditional values and commitment to excellence.

- Innovative Solutions: Of Kos expands its capabilities to deliver targeted patient engagement, robust digital strategies, effective traditional marketing, and in-depth analytics to meet diverse client needs.

- Strategic Growth: This rebranding is a strategic move to strengthen their market presence and support their long-term growth objectives in the healthcare sector.

- Client Engagement: The new brand is designed to better connect with healthcare professionals, ensuring their services are perceived as both relevant and cutting-edge.

The Future of Healthcare Solutions

Of Kos is repositioning itself in the market to broaden its view and enhance its capacity to serve patients in new ways. With boutique medical marketing agency solutions, doctors and healthcare providers can increase their visibility among the right people while improving the overall patient experience.

But whether Of Kos is facilitating faster test results or offering a diagnostic marketing approach to growing medical practices, the goal is to revolutionize the standard of care and build connections for a healthier future.

ONAR CEO, Claude Zdanow, commented on the Of Kos rebranding, stating "Our decision to rebrand VMed to Of Kos reflects our commitment to staying ahead of the curve in the ever-evolving healthcare marketing landscape. 'Of Kos' not only represents a fresh, cutting-edge identity but also underscores our dedication to providing innovative solutions that bridge the gap between healthcare organizations and their patients. We believe this new brand will better resonate with our clients and partners, showcasing our forward-thinking approach and our vision for the future of healthcare marketing."

ONAR's President, Chris Becker, also expressed excitement about the opportunity: "This acquisition aligns with our strategy of expanding into high-growth niche markets. With their expertise and connections in the healthcare field, we're confident in our ability to deliver disruptive solutions and create long-term value for not only our clients and shareholders, but for doctors and patients too."

For more information about Of Kos, visit www.ofkos.com.

About ONAR

ONAR (OTCQB:RELT) is a dynamic marketing and business solutions network, currently publicly traded as Reliant Holdings, Inc. with plans to become Onar Holding Corporation in the near future. ONAR's mission is to provide unparalleled service through an integrated, AI-driven approach, leveraging its diverse brand family's strengths. Committed to honor, candor, and best-in-class results, ONAR aims to lead the industry by example, ensuring every client relationship is deeply rooted in trust and excellence.

Learn more at www.onar.com.

About Of Kos

Of Kos is a leading healthcare marketing agency dedicated to connecting healthcare organizations and laboratories with innovative marketing solutions. With deep expertise in the medical laboratory and genetic testing sectors, Of Kos understands the unique challenges faced by healthcare providers. We offer strategic communications, marketing, and solutions-oriented partnerships to help our clients effectively educate providers about the latest advancements in healthcare, reach more patients, and ultimately provide better care.

For more information, visit: www.ofkos.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ONAR's current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy, and financial needs. These statements are not historical facts and are inherently uncertain and outside of ONAR's control. Forward-looking statements include, among other things, statements regarding ONAR's expectations regarding its ability to achieve its financial and strategic goals, including surpassing $100 million in revenue and securing a NASDAQ listing; its ability to expand its client base and market share; and its ability to develop and launch new products and services. Actual results may differ materially from ONAR's expectations and projections due to various risks and uncertainties, including market conditions, competition, the ability to protect intellectual property, the ability to manage growth, changes in laws and regulations, and other factors described in ONAR's filings with the Securities and Exchange Commission. These forward-looking statements are made as of the date of this press release, and ONAR undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Contact Information

Sara Wetmore
Marketing Manager, ONAR
[email protected]
213-437-3081

SOURCE: ONAR

J.P.Estrada--TFWP